These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21876870)

  • 1. Hard beta and gamma emissions of 124I. Impact on occupational dose in PET/CT.
    Kemerink GJ; Franssen R; Visser MG; Urbach CJ; Halders SG; Frantzen MJ; Brans B; Teule GJ; Mottaghy FM
    Nuklearmedizin; 2011; 50(6):240-6. PubMed ID: 21876870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technologist radiation exposure in routine clinical practice with 18F-FDG PET.
    Guillet B; Quentin P; Waultier S; Bourrelly M; Pisano P; Mundler O
    J Nucl Med Technol; 2005 Sep; 33(3):175-9. PubMed ID: 16145226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I.
    Pettinato C; Monari F; Nanni C; Allegri V; Marcatili S; Civollani S; Cima S; Spezi E; Mazzarotto R; Fanti S
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):509-14. PubMed ID: 23358403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The introduction of automated dispensing and injection during PET procedures: a step in the optimisation of extremity doses and whole-body doses of nuclear medicine staff.
    Covens P; Berus D; Vanhavere F; Caveliers V
    Radiat Prot Dosimetry; 2010 Aug; 140(3):250-8. PubMed ID: 20335185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation exposure of patients and personnel from a PET/CT procedure with 18F-FDG.
    Leide-Svegborn S
    Radiat Prot Dosimetry; 2010; 139(1-3):208-13. PubMed ID: 20167792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupational radiation dosimetry assessment using an automated infusion device for positron-emitting radiotracers.
    Schleipman AR; Gerbaudo VH
    J Nucl Med Technol; 2012 Dec; 40(4):244-8. PubMed ID: 23024340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer.
    Jentzen W; Freudenberg L; Eising EG; Sonnenschein W; Knust J; Bockisch A
    J Nucl Med; 2008 Jun; 49(6):1017-23. PubMed ID: 18483099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations.
    Brix G; Lechel U; Glatting G; Ziegler SI; Münzing W; Müller SP; Beyer T
    J Nucl Med; 2005 Apr; 46(4):608-13. PubMed ID: 15809483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation dose to PET technologists and strategies to lower occupational exposure.
    Roberts FO; Gunawardana DH; Pathmaraj K; Wallace A; U PL; Mi T; Berlangieri SU; O'Keefe GJ; Rowe CC; Scott AM
    J Nucl Med Technol; 2005 Mar; 33(1):44-7. PubMed ID: 15731021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doses to nuclear technicians in a dedicated PET/CT centre utilising 18F fluorodeoxyglucose (FDG).
    Seierstad T; Stranden E; Bjering K; Evensen M; Holt A; Michalsen HM; Wetteland O
    Radiat Prot Dosimetry; 2007; 123(2):246-9. PubMed ID: 16987913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical modeling of the radiation dose received from photons passing over and through shielding walls in a PET/CT suite.
    Fog LS; Cormack J
    Health Phys; 2010 Dec; 99(6):769-79. PubMed ID: 21068595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight-based, low-dose pediatric whole-body PET/CT protocols.
    Alessio AM; Kinahan PE; Manchanda V; Ghioni V; Aldape L; Parisi MT
    J Nucl Med; 2009 Oct; 50(10):1570-7. PubMed ID: 19793734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personnel exposure in labelling and administration of (177)Lu-DOTA-D-Phe1-Tyr3-octreotide.
    Sghedoni R; Grassi E; Fioroni F; Asti M; Piccagli V; Versari A; Iori M
    Nucl Med Commun; 2011 Oct; 32(10):947-53. PubMed ID: 21876406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deriving staff and public doses in a PET/CT facility from measured radiation levels using thermoluminescent dosimetry.
    Al-Haj AN; Lobriguito AM; Arafah A; Parker R
    Radiat Prot Dosimetry; 2011 Mar; 144(1-4):487-91. PubMed ID: 21147788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure of medical personnel to radiation during radionuclide therapy practices.
    Lancelot S; Guillet B; Sigrist S; Bourrelly M; Waultier S; Mundler O; Pisano P
    Nucl Med Commun; 2008 Apr; 29(4):405-10. PubMed ID: 18317307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.
    Beauregard JM; Croteau E; Ahmed N; van Lier JE; Bénard F
    J Nucl Med; 2009 Jan; 50(1):100-7. PubMed ID: 19091905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of occupational exposure to photon rays in Poland, 2006].
    Jankowski J; Kacprzyk J; Tybor-Czerwińska M; Kamiński Z
    Med Pr; 2007; 58(4):287-90. PubMed ID: 18041197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of annual whole-body occupational radiation exposure in Ireland (1996-2005).
    Colgan PA; Currivan L; Fenton D
    Radiat Prot Dosimetry; 2008; 128(1):12-20. PubMed ID: 17562657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation dose estimates in humans for (11)C-acetate whole-body PET.
    Seltzer MA; Jahan SA; Sparks R; Stout DB; Satyamurthy N; Dahlbom M; Phelps ME; Barrio JR
    J Nucl Med; 2004 Jul; 45(7):1233-6. PubMed ID: 15235071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.